These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20617594)

  • 1. Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.
    Ogra PL; Karzon DT; Righthand F; MacGillivray M
    N Engl J Med; 1968 Oct; 279(17):893-900. PubMed ID: 20617594
    [No Abstract]   [Full Text] [Related]  

  • 2. The final stages of the global eradication of polio.
    John TJ
    N Engl J Med; 2000 Sep; 343(11):806-7. PubMed ID: 10984572
    [No Abstract]   [Full Text] [Related]  

  • 3. Poliomyelitis immunity status in Italian and foreign subjects.
    Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
    Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
    [No Abstract]   [Full Text] [Related]  

  • 4. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving and maintaining polio eradication--new strategies.
    Modlin J; Wenger J
    N Engl J Med; 2014 Oct; 371(16):1476-9. PubMed ID: 25317869
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains.
    Minor PD; Dunn G; Ramsay ME; Brown D
    J Med Virol; 2005 Jan; 75(1):153-60. PubMed ID: 15543587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.
    Herremans TM; Reimerink JH; Buisman AM; Kimman TG; Koopmans MP
    J Immunol; 1999 Apr; 162(8):5011-8. PubMed ID: 10202050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
    Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
    J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
    Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
    J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal immunity following a combined enhanced inactivated polio vaccine/oral polio vaccine programme in Israel.
    Swartz TA; Green MS; Handscher R; Sofer D; Cohen-Dar M; Shohat T; Habib S; Barak E; Dror Z; Somekh E; Peled-Leviathan T; Yulzari R; Libling A; Mendelson E; Shulman LM
    Vaccine; 2008 Feb; 26(8):1083-90. PubMed ID: 18241962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The final phase of polio eradication: new vaccines and complex choices.
    Cochi SL; Linkins RW
    J Infect Dis; 2012 Jan; 205(2):169-71. PubMed ID: 22158681
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New poliovirus vaccine schedules.
    Zhang Q; Leppold C; Shao Y; Mura Y; Tanimoto T
    Lancet; 2016 Nov; 388(10059):2477-2478. PubMed ID: 27871742
    [No Abstract]   [Full Text] [Related]  

  • 14. Antibody to poliovirus in older children and young adults in Israel and the use of poliovaccines for the immunization of the seronegatives.
    Goldblum N; Kra-Oz Z; Swartz T
    Dev Biol Stand; 1979; 43():173-7. PubMed ID: 230108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive poliomyelitis immunization].
    Böthig B
    Z Arztl Fortbild (Jena); 1990; 84(8):365-7. PubMed ID: 2165712
    [No Abstract]   [Full Text] [Related]  

  • 16. Low oral poliovirus vaccine immunogenicity in developing countries.
    Orenstein WA; Garon JR
    Lancet Infect Dis; 2016 Aug; 16(8):868-9. PubMed ID: 27156190
    [No Abstract]   [Full Text] [Related]  

  • 17. Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.
    Julkunen I; Ukkonen P; Stenvik M; Hovi T; Renkonen L; Mäkelä O
    J Clin Immunol; 1987 Jul; 7(4):319-26. PubMed ID: 3611298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of inactivated poliomyelitis vaccine for primary vaccination].
    Li CG; Ying ZF; Wang JF; Fang HH; Li YP; Li RC; Bonnet MC; Zhang YP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):501-3. PubMed ID: 19950717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG oligodeoxynucleotides are a potent adjuvant for an inactivated polio vaccine produced from Sabin strains of poliovirus.
    Yang C; Shi H; Zhou J; Liang Y; Xu H
    Vaccine; 2009 Nov; 27(47):6558-63. PubMed ID: 19729087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Response of revaccination against polio I in seronegative children after receiving 3 or more doses of the vaccine].
    Ruiz-Gómez J; Sánchez Burgos Y; Arrayales Sandoval F; Velázquez Zúñiga C
    Gac Med Mex; 1977 Jan; 113(1):23-7. PubMed ID: 863152
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.